Solera Health's $40 million Series E round was co-led by Health Care Service Corporation and included participation from ...

Patient flow automation startup Qventus closed a $105 million Series D financing round. The company’s technology is used by ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

Technology often plays a critical role in strategies to combat rising costs while maintaining quality care. Here are four ...

Recent research shows almost half of U.S. counties don’t have a practicing cardiologist. The fact that more than 22 million Americans must travel nearly 90 miles round trip to seek this ...

Amazon’s health benefits program continues to expand. Amazon customers eligible for Teladoc Health’s services in diabetes, hypertension, pre-diabetes and weight management can now enroll ...

Last year’s M&A activity in the healthcare sector signaled an unsteady financial recovery for the nation’s hospitals, according to a new report from Kaufman Hall. The report found that there ...

The digital era is gradually taking over our institutional memory in healthcare. Every year, the next generation of physicians enters the workforce with no lived experience of a paper-based ...

Pfizer Chairman and CEO Albert Bourla did not mince his words at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco on Monday regarding the controversial positions that Robert F.

A blockbuster AstraZeneca drug may now be used as an earlier treatment for mantle cell lymphoma (MCL), making it the first in its class approved as a first-line therapy for this rare and ...

When it comes to AI in healthcare, it’s common for people to feel uncertain. Patients wonder: Will AI change the way care feels? Will it affect the trust and connection I expect from providers?

Imagine a patient with breast cancer, who’s been prescribed a standard chemotherapy treatment. The patient completes the treatment only to find out the cancer is still spreading. Upon further ...